&Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $598K | Sell |
3,940
-4,805
| -55% | -$729K | ﹤0.01% | 1263 |
|
|
2025
Q1 | $1.36M | Buy |
8,745
+1,128
| +15% | +$175K | 0.01% | 702 |
|
|
2024
Q4 | $1.42M | Buy |
7,617
+1,614
| +27% | +$301K | 0.02% | 622 |
|
|
2024
Q3 | $1.18M | Buy |
6,003
+2,708
| +82% | +$533K | 0.02% | 507 |
|
|
2024
Q2 | $681K | Buy |
+3,295
| New | +$681K | 0.03% | 443 |
|